4-[3-Chloro-4-(3-fluorobenzyloxy)phenylamino]-6-iodoquinazolin

97%

  • Product Code: 66350
  Alias:    N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine; 4-[3-chloro-4-(3-fluorobenzyloxy)aniline Base] -6-iodoquinazoline
  CAS:    231278-20-9
Molecular Weight: 505.72 g./mol Molecular Formula: C₂₁H₁₄ClFIN₃O
EC Number: MDL Number: MFCD09998827
Melting Point: Boiling Point:
Density: Storage Condition: room temperature, sealed
Product Description: This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of targeted cancer therapies, particularly in the development of tyrosine kinase inhibitors. These inhibitors are designed to block specific enzymes involved in the growth and proliferation of cancer cells, making it a valuable component in the creation of drugs for treating various types of cancers, such as lung, breast, and colorectal cancer. Additionally, its structural properties make it a candidate for further modification to enhance its efficacy and selectivity in inhibiting tumor growth. Researchers also explore its potential in combination therapies to improve treatment outcomes and reduce resistance in cancer patients.
Product Specification:
Test Specification
Purity 96.5-100
Melting point 223-227
APPEARANCE WHITE TO LIGHT YELLOW POWDER OR CRYSTALS
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
1.000 10-20 days $11.80
+
-
5.000 10-20 days $21.63
+
-
25.000 10-20 days $73.15
+
-
4-[3-Chloro-4-(3-fluorobenzyloxy)phenylamino]-6-iodoquinazolin
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of targeted cancer therapies, particularly in the development of tyrosine kinase inhibitors. These inhibitors are designed to block specific enzymes involved in the growth and proliferation of cancer cells, making it a valuable component in the creation of drugs for treating various types of cancers, such as lung, breast, and colorectal cancer. Additionally, its structural properties make it a candidate for further modification to enhance its efficacy and selectivity in inhibiting tumor growth. Researchers also explore its potential in combination therapies to improve treatment outcomes and reduce resistance in cancer patients.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page